Well, IANAL, but if Oracle had "paid the taxes" on their prize, that would probably have been counted as income to the recipient in addition to the cash value of the prize. I don't think that in this case there is any practical way to be compliant without the recipient declaring all funds or items of value received as income.
There is a lot of interesting research on using non-embryonic stem cells from tissue like bone marrow. Should it pan out, and the possibility is at least as great as that for using embryonic ones, it would avoid the controversial use of aborted fetuses for developing stem cells for future therapy.
Slashdot Mirror
Well, IANAL, but if Oracle had "paid the taxes" on their prize, that would probably have been counted as income to the recipient in addition to the cash value of the prize. I don't think that in this case there is any practical way to be compliant without the recipient declaring all funds or items of value received as income.
There is a lot of interesting research on using non-embryonic stem cells from tissue like bone marrow. Should it pan out, and the possibility is at least as great as that for using embryonic ones, it would avoid the controversial use of aborted fetuses for developing stem cells for future therapy.